Telix Pharmaceuticals Ltd (TLX) stock
TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
$8.86−0.06 (-0.73%)
Close on Nov 17, 2026Market cap $3.00BP/E –Yield –
Telix Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Telix Pharmaceuticals's total assets was $1.36B at Jun 30, 2026. For fiscal 2025 it was $1.16B, up 23.8% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.16B | +23.8% |
| FY2024 | Dec 31, 2024 | $940.38M | +239.2% |
| FY2023 | Dec 31, 2023 | $277.26M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.36B | – |
| Q4 FY2025 | Dec 31, 2025 | $1.16B | – |
| Q4 FY2024 | Dec 31, 2024 | $940.38M | – |
| Q4 FY2023 | Dec 31, 2023 | $277.26M | – |
See a number that looks wrong?